🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/11/1979 | 1,85 | 1,88 | 1,85 | 1,88 | +1,80% | 1,79% | 2.806.963 |
| 21/11/1979 | 1,83 | 1,85 | 1,78 | 1,84 | +0,54% | 3,62% | 2.701.325 |
| 20/11/1979 | 1,82 | 1,84 | 1,81 | 1,83 | +0,91% | 1,64% | 1.146.931 |
| 19/11/1979 | 1,82 | 1,86 | 1,81 | 1,82 | -0,37% | 2,55% | 1.852.445 |
| 16/11/1979 | 1,84 | 1,87 | 1,82 | 1,82 | -1,07% | 2,33% | 1.614.758 |
| 15/11/1979 | 1,83 | 1,86 | 1,83 | 1,84 | +0,90% | 1,63% | 4.625.453 |
| 14/11/1979 | 1,80 | 1,83 | 1,77 | 1,83 | +1,47% | 3,32% | 2.557.958 |
| 13/11/1979 | 1,81 | 1,81 | 1,79 | 1,80 | -0,91% | 1,10% | 1.177.114 |
| 12/11/1979 | 1,75 | 1,82 | 1,75 | 1,82 | +3,59% | 3,59% | 1.184.659 |
| 09/11/1979 | 1,73 | 1,76 | 1,73 | 1,75 | +1,93% | 1,91% | 1.041.293 |
| 08/11/1979 | 1,73 | 1,76 | 1,72 | 1,72 | -0,39% | 2,69% | 4.112.352 |
| 07/11/1979 | 1,74 | 1,74 | 1,72 | 1,73 | -0,57% | 1,34% | 2.754.144 |
| 06/11/1979 | 1,74 | 1,74 | 1,73 | 1,74 | -0,76% | 0,76% | 1.018.656 |
| 05/11/1979 | 1,76 | 1,76 | 1,73 | 1,75 | -0,75% | 1,32% | 788.515 |
| 02/11/1979 | 1,76 | 1,78 | 1,76 | 1,76 | +0,00% | 1,13% | 946.973 |
| 01/11/1979 | 1,75 | 1,77 | 1,75 | 1,76 | +0,56% | 1,13% | 1.482.710 |
| 31/10/1979 | 1,77 | 1,78 | 1,75 | 1,75 | -1,12% | 1,49% | 1.260.115 |
| 30/10/1979 | 1,74 | 1,77 | 1,73 | 1,77 | +2,10% | 2,67% | 1.256.342 |
| 29/10/1979 | 1,74 | 1,76 | 1,74 | 1,74 | -0,38% | 1,14% | 2.063.722 |
| 26/10/1979 | 1,73 | 1,74 | 1,73 | 1,74 | +1,35% | 0,96% | 1.509.120 |
| 25/10/1979 | 1,72 | 1,75 | 1,71 | 1,72 | +0,19% | 2,32% | 1.814.717 |
| 24/10/1979 | 1,71 | 1,73 | 1,70 | 1,72 | +0,19% | 1,74% | 1.905.264 |
| 23/10/1979 | 1,73 | 1,73 | 1,70 | 1,71 | -0,77% | 1,73% | 2.078.813 |
| 22/10/1979 | 1,71 | 1,73 | 1,69 | 1,73 | +0,78% | 2,32% | 3.753.936 |
| 19/10/1979 | 1,75 | 1,75 | 1,71 | 1,71 | -2,27% | 1,90% | 3.889.757 |
| 18/10/1979 | 1,75 | 1,77 | 1,75 | 1,75 | +0,19% | 0,94% | 1.429.891 |
| 17/10/1979 | 1,75 | 1,77 | 1,75 | 1,75 | +0,38% | 1,33% | 1.810.944 |
| 16/10/1979 | 1,73 | 1,76 | 1,73 | 1,74 | +0,96% | 1,34% | 2.199.542 |
| 15/10/1979 | 1,74 | 1,76 | 1,71 | 1,73 | -0,57% | 2,67% | 3.995.395 |
| 12/10/1979 | 1,74 | 1,76 | 1,74 | 1,74 | +0,00% | 1,15% | 2.591.914 |